Correlation of level of gangliosides in plasma with cancer in human patients

Journal of Experimental and Clinical Cancer Research

Volumn 19, Issue 3, 2000, Pages 317-327

  Mondal, S ^a   Saha, S ^a  

^a CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

Author keywords

Ganglioside; Human cancer

Indexed keywords

GANGLIOSIDE;

ADULT; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER GROWTH; CANCER PATIENT; CANCER STAGING; CONTROLLED STUDY; DENSITOMETRY; FACE CANCER; FEMALE; HUMAN; LIPID BLOOD LEVEL; MALE; PENIS CANCER; PRIORITY JOURNAL; PROGNOSIS; THIN LAYER CHROMATOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GANGLIOSIDES; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0033765034     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Cellular and humoral immunity to rat hepatoma-specific antigen correlated with tumor status
2. Elution of 'blocking factors' from human tumors, capable of abrogating tumor-cell destruction by specifically immune lymphocytes
3. Sequestation of macrophages in growing tumors and its effect on the immunological capacity of the host
4. Inhibition of pulmonary metastasis by intravenous injection of specifically activated macrophages
5. Suggestive evidence that the 'blocking antibodies' of tumorbearing individuals may be antigen-antibody complexes
6. Escape from immune destruction by the host through shedding of surface antigens: Is this a characteristic shared by malignant and embryonic cells?
7. Activation of suppressor T cells by tumor cells and specific antibody
8. Evidence of suppressor cell activity in spleens of mice bearing primary tumor induced by Moloney sarcoma virus
9. Regulation of the immune response to tumor antigens. I. Immunosuppressive cells in tumor-bearing hosts
10. Inhibition of cell-mediated cytotoxicity to chemically-induced rat tumors by soluble tumor and embryo cell extracts
11. Regulation of the immune response to tumor antigens. III. Characterization of thymic suppressor factor(s) produced by tumor-bearing host
12. Glycopeptide changes and malignant transformation. A possible role for carbohydrate in malignant behavior
13. α-L-Fucopyranosylceramide, a novel glycolipid accumulated in some of the human colon tumors
14. Association of the glycolipid pattern with antigenic alterations in mouse fibroblast transformed by murine sarcoma virus
15. Neutral fucolipids and fucogangliosides of rat hepatoma HTC and H-35 cells, rat liver and hepatocytes
16. Isolation and characterization of a new fucoganglioside accumulated in precancerous rat liver and in rat hepatoma induced by N-2-acetylaminofluorene
17. Isoantigenic expression of Forssman glycolipid in human gastric mucosa, possibly identity with 'A-like antigen' in human cancers
18. Blood group A-like antigen and a novel Forssman antigen in the hepatocarcinoma of human group O individual
19. Regulation of lymphocyte response by human gangliosides
20. Shedding and immunoregulatory activity of YAC-1 lymphoma cell gangliosides
21. Inhibition of mitogen- and antigen-induced lymphocyte activation by human leukemia cell gangliosides
22. Inhibition of interleukin-2 dependent cytotoxic T-lymphocyte growth by gangliosides
23. Modulation of immune response by gangliosides: Inhibition of adherant monocyte accessory function in vitro
24. Effect of gangliosides on the cytotoxic activity of natural killers from Syrian hamsters
25. Specific inhibition of human natural killer cell-mediated cytotoxicity by sialic acid and sialo-oligosaccarides
26. Modulation of B-cell response by glycolipid released from antigen stimulated T-cells
27. Release of Thy-1,2 and Thy1,1 from lymphoblastoid cells: Partial characterization and antigenicity of shed material
28. Structure and organization of cell surface glycolipids. Dependence on cell growth and malignant transformation
29. Glycolipids of chick embryo fibroblasts infected with temperature-sensitive mutants of avian sarcoma viruses
30. The long-chain neutral glycolipids and gangliosides of murine fibroblast lines and their low and high tumorigenic hybrids
31. Metastatic potential is positively correlated with cell surface sialylation of cultured murine cells
32. Gangliosides shed by tumor cells enhance tumor formation in mice
33. Abrogation of shedding of immunosuppressive neuroblastoma Gangliosides
34. Changes in plasma gangliosides in relation to tumor growth and their tumor-enhancing effect
35. Effect of plasma gangliosides on the growth of Ehrlich ascites Tumor
36. Changes in plasma gangliosides in relation to tumor growth modified by vitamin A
37. Detection and resolution of gangliosides in lipid extracts by thin layer chromatography
38. Quantitative estimation of sialic acid. II. A colorimetric resorcinol-hydrochloric acid method
39. Use of monoclonal antibodies to sialylated Lewisx and sialylated Lewison for serological test of cancer
40. CA 19-9 and carcinoembryonic antigen in pancreatic cancer diagnosis
41. Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens
42. Monoclonal antibodies against gastrointestinal tumor-associated antigens isolated as monosialogangliosides
43. Detection by monoclonal antibody of carbohydrate antigen CA-50 in serum of patients with carcinoma